Clinical Trials Directory

Trials / Completed

CompletedNCT01290250

Evaluation of a New Orange-Based Beverage Enriched With Polyphenols in Adult Humans

Evaluation of a New Orange-Based Beverage Enriched With Polyphenols (Whole Press) on Features of Metabolic Syndrome and Cardiovascular Risk Factors Related to Inflammation and Antioxidant Defense System in Adult Humans

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
210 (actual)
Sponsor
The Coca-Cola Company · Industry
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the effects of a new orange juice-based beverage enriched in fiber and selected phenolic compounds (mainly flavanones) on features of metabolic syndrome and cardiovascular disease risk factors related to inflammation and antioxidant defense system in overweight and obese adult humans. This study hypothesizes that consumption of an orange juice-based beverage enriched in fiber and selected phenolic compounds (mainly flavanones)would improve lipid levels and lipid metabolism,blood pressure and the Homeostatic Model Assessment (HOMA) index.

Conditions

Interventions

TypeNameDescription
OTHEROrange juice based beverage enriched in polyphenols2 daily doses (250 ml each) during 3 months

Timeline

Start date
2010-02-01
Primary completion
2011-01-01
Completion
2012-07-01
First posted
2011-02-04
Last updated
2013-03-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01290250. Inclusion in this directory is not an endorsement.